| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327502 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
HLA-G is expressed in a significant number of ovarian carcinomas at all anatomic sites. The reduced expression of HLA-G in post-chemotherapy effusions and its correlation with improved survival may be related to preferential susceptibility of HLA-G-expressing cells at this site. Our findings suggest a new role for HLA-G as a prognostic indicator in advanced-stage ovarian cancer in effusions.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ben Davidson, Mari Bukholt Elstrand, Michael T. McMaster, Aasmund Berner, Robert J. Kurman, Björn Risberg, Claes G. Trope, Ie-Ming Shih,